Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Vaccines

  Free Subscription


Articles published in Arch Virol

Retrieve available abstracts of 44 articles:
HTML format
Text format



Single Articles


    October 2017
  1. KRISHNAVAJHALA HR, Williams J, Heidner H
    An influenza A virus vaccine based on an M2e-modified alphavirus.
    Arch Virol. 2017 Oct 27. doi: 10.1007/s00705-017-3578.
    PubMed     Text format     Abstract available


    September 2017
  2. TURMAGAMBETOVA AS, Alexyuk PG, Bogoyavlenskiy AP, Zaitseva IA, et al
    Adjuvant activity of saponins from Kazakhstani plants on the immune responses to subunit influenza vaccine.
    Arch Virol. 2017 Sep 21. doi: 10.1007/s00705-017-3560.
    PubMed     Text format     Abstract available


    August 2017
  3. SONG Y, Fan Z, Zuo Y, Wei H, et al
    Binding of rabbit hemorrhagic disease virus-like particles to host histo-blood group antigens is blocked by antisera from experimentally vaccinated rabbits.
    Arch Virol. 2017 Aug 5. doi: 10.1007/s00705-017-3509.
    PubMed     Text format     Abstract available


  4. ZHUGUNISSOV K, Bulatov Y, Taranov D, Yershebulov Z, et al
    Protective immune response of oral rabies vaccine in stray dogs, corsacs and steppe wolves after a single immunization.
    Arch Virol. 2017 Aug 1. doi: 10.1007/s00705-017-3499.
    PubMed     Text format     Abstract available


    July 2017
  5. ORABI A, Hussein A, Saleh AA, El-Magd MA, et al
    Evolutionary insights into the fusion protein of Newcastle disease virus isolated from vaccinated chickens in 2016 in Egypt.
    Arch Virol. 2017 Jul 8. doi: 10.1007/s00705-017-3483.
    PubMed     Text format     Abstract available


    June 2017
  6. FENG S, Wang C, Hu S, Wu Q, et al
    Recent progress in the development of white spot syndrome virus vaccines for protecting shrimp against viral infection.
    Arch Virol. 2017 Jun 24. doi: 10.1007/s00705-017-3450.
    PubMed     Text format     Abstract available


  7. LEITE FGG, Torres AA, De Oliveira LC, Da Cruz AFP, et al
    c-Jun integrates signals from both MEK/ERK and MKK/JNK pathways upon vaccinia virus infection.
    Arch Virol. 2017 Jun 15. doi: 10.1007/s00705-017-3446.
    PubMed     Text format     Abstract available


  8. SHARMA KK, Kalyani IH, Mohapatra J, Patel SD, et al
    Evaluation of the oncolytic potential of R2B Mukteshwar vaccine strain of Newcastle disease virus (NDV) in a colon cancer cell line (SW-620).
    Arch Virol. 2017 Jun 3. doi: 10.1007/s00705-017-3411.
    PubMed     Text format     Abstract available


    May 2017
  9. XIAO X, Zhang Y, Wei Q, Yin X, et al
    Flagellin FljB as an adjuvant to the recombinant adenovirus rabies glycoprotein vaccine increases immune responses against rabies in mice.
    Arch Virol. 2017 May 26. doi: 10.1007/s00705-017-3413.
    PubMed     Text format     Abstract available


  10. LEITE FGG, Bergthaler A, Skern T
    Vaccinia virus G1 protein: absence of autocatalytic self-processing.
    Arch Virol. 2017 May 18. doi: 10.1007/s00705-017-3409.
    PubMed     Text format     Abstract available


    April 2017
  11. RODRIGUEZ LAY LLA, Bello Corredor M, Montalvo Villalba MC, Chibas Ojeda AG, et al
    Hepatitis B virus infection assessed 3 to 18 years after vaccination in Cuban children and adolescents born to HBsAg-positive mothers.
    Arch Virol. 2017 Apr 24. doi: 10.1007/s00705-017-3365.
    PubMed     Text format     Abstract available


  12. VALDES I, Marcos E, Suzarte E, Perez Y, et al
    A dose-response study in mice of a tetravalent vaccine candidate composed of domain III-capsid proteins from dengue viruses.
    Arch Virol. 2017 Apr 9. doi: 10.1007/s00705-017-3360.
    PubMed     Text format     Abstract available


  13. COSTA GB, Lavergne A, Darcissac E, Lacoste V, et al
    Absence of vaccinia virus detection in a remote region of the Northern Amazon forests, 2005-2015.
    Arch Virol. 2017 Apr 7. doi: 10.1007/s00705-017-3353.
    PubMed     Text format     Abstract available


  14. YOGISHARADHYA R, Kumar A, Ramappa R, Venkatesan G, et al
    Functional characterization of recombinant major envelope protein (rB2L) of orf virus.
    Arch Virol. 2017;162:953-962.
    PubMed     Text format     Abstract available


    March 2017
  15. SHAH MS, Ashraf A, Khan MI, Rahman M, et al
    Fowl adenovirus: history, emergence, biology and development of a vaccine against hydropericardium syndrome.
    Arch Virol. 2017 Mar 10. doi: 10.1007/s00705-017-3313.
    PubMed     Text format     Abstract available


    February 2017
  16. KWAK BO, Lee HJ, Kang HM, Oh CE, et al
    Genotype analysis of ORF 62 identifies varicella-zoster virus infections caused by a vaccine strain in children.
    Arch Virol. 2017 Feb 15. doi: 10.1007/s00705-017-3276.
    PubMed     Text format     Abstract available


  17. WU W, Liu S, Yu P, Tao X, et al
    Role of systemic injection of rabies immunoglobulin in rabies vaccination.
    Arch Virol. 2017 Feb 10. doi: 10.1007/s00705-017-3263.
    PubMed     Text format     Abstract available


  18. ZHANG M, Ge J, Wen Z, Chen W, et al
    Characterization of a recombinant Newcastle disease virus expressing the glycoprotein of bovine ephemeral fever virus.
    Arch Virol. 2017;162:359-367.
    PubMed     Text format     Abstract available


    January 2017
  19. FOTOUHI F, Shaffifar M, Farahmand B, Shirian S, et al
    Adjuvant use of the NKT cell agonist alpha-galactosylceramide leads to enhancement of M2-based DNA vaccine immunogenicity and protective immunity against influenza A virus.
    Arch Virol. 2017 Jan 24. doi: 10.1007/s00705-017-3230.
    PubMed     Text format     Abstract available


    December 2016
  20. ANDOH K, Yamazaki K, Honda Y, Honda T, et al
    Turkey herpesvirus with an insertion in the UL3-4 region displays an appropriate balance between growth activity and antibody-eliciting capacity and is suitable for the establishment of a recombinant vaccine.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


    November 2016
  21. MOEINI S, Saeidi M, Fotouhi F, Mondanizadeh M, et al
    Erratum to: Synergistic effect of programmed cell death protein 1 blockade and secondary lymphoid tissue chemokine in the induction of anti-tumor immunity by a therapeutic cancer vaccine.
    Arch Virol. 2016.
    PubMed     Text format    


  22. ZHOU Y, Yang X, Wang H, Zeng F, et al
    The establishment and characteristics of cell-adapted IBV strain H120.
    Arch Virol. 2016;161:3179-87.
    PubMed     Text format     Abstract available


    October 2016
  23. ASTRAY RM, Jorge SA, Pereira CA
    Rabies vaccine development by expression of recombinant viral glycoprotein.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  24. LI J, Yu T, Zhang F, Wang X, et al
    Inactivated chimeric porcine circovirus (PCV) 1-2 vaccines based on genotypes 2b and 2d exhibit similar immunological effectiveness in protecting pigs against challenge with PCV2b strain 0233.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  25. MIAO FM, Zhang SF, Wang SC, Liu Y, et al
    Comparison of immune responses to attenuated rabies virus and street virus in mouse brain.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  26. SUN Y, Yang C, Li J, Li L, et al
    Construction of a recombinant duck enteritis virus vaccine expressing hemagglutinin of H9N2 avian influenza virus and evaluation of its efficacy in ducks.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  27. MOEINI S, Saeidi M, Fotouhi F, Mondanizdeh M, et al
    Synergistic effect of programmed cell death protein 1 blockade and secondary lymphoid tissue chemokine in the induction of anti-tumor immunity by a therapeutic cancer vaccine.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


    September 2016
  28. MADAPONG A, Temeeyasen G, Saeng-Chuto K, Tripipat T, et al
    Humoral immune responses and viral shedding following vaccination with modified live porcine reproductive and respiratory syndrome virus vaccines.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  29. AGHASADEGHI MR, Velayati AA, Mamishi S, Nabavi M, et al
    Low prevalence of hepatitis B vaccine escape mutants among individuals born after the initiation of a nationwide vaccination program in Iran.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  30. ZHU Y, Wang GH, Cui YD, Cui SJ, et al
    Establishment of a nanoparticle-assisted RT-PCR assay to distinguish field strains and attenuated strains of porcine epidemic diarrhea virus.
    Arch Virol. 2016;161:2543-7.
    PubMed     Text format     Abstract available


    July 2016
  31. ANDRADE LG, Albarnaz JD, Mugge FL, David BA, et al
    Vaccinia virus dissemination requires p21-activated kinase 1.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  32. SAMY A, El-Enbaawy MI, El-Sanousi AA, Nasef SA, et al
    Initiation and regulation of immune responses to immunization with whole inactivated vaccines prepared from two genetically and antigenically distinct lineages of Egyptian influenza A virus subtype H5N1.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  33. QUINTILIO W, de Freitas FA, Rodriguez D, Kubrusly FS, et al
    Vitamins as influenza vaccine adjuvant components.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  34. NAVID MT, Li Y, Zhou M, Cui M, et al
    Comparison of the immunogenicity of two inactivated recombinant rabies viruses overexpressing the glycoprotein.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


    June 2016
  35. MENG XY, Luo Y, Liu Y, Shao L, et al
    A triplex real-time PCR for differential detection of classical, variant and Bartha-K61 vaccine strains of pseudorabies virus.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  36. MORIMOTO K, Khawplod P, Sato Y, Virojanapirom P, et al
    Rabies vaccination at a virus-inoculated site as an alternative option to rabies immunoglobulin.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  37. JAGADESH A, Salam AA, Mudgal PP, Arunkumar G, et al
    Influenza virus neuraminidase (NA): a target for antivirals and vaccines.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  38. BALL C, Forrester A, Ganapathy K
    Detection of variant infectious bronchitis viruses in Sri Lanka (2012-2015).
    Arch Virol. 2016;161:1697-9.
    PubMed     Text format     Abstract available


  39. SVIBEN D, Forcic D, Kurtovic T, Halassy B, et al
    Stability, biophysical properties and effect of ultracentrifugation and diafiltration on measles virus and mumps virus.
    Arch Virol. 2016;161:1455-67.
    PubMed     Text format     Abstract available


    March 2016
  40. GE F, Li X, Ju H, Yang D, et al
    Genotypic evolution and antigenicity of H9N2 influenza viruses in Shanghai, China.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  41. JIN H, Xia X, Liu B, Fu Y, et al
    High-yield production of canine parvovirus virus-like particles in a baculovirus expression system.
    Arch Virol. 2016;161:705-10.
    PubMed     Text format     Abstract available


    February 2016
  42. TEWAWONG N, Chansaenroj J, Klinfueng S, Vichiwattana P, et al
    Lineage-specific detection of influenza B virus using real-time polymerase chain reaction with melting curve analysis.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


    January 2016
  43. CHEN Y, He S, Sun L, Luo Y, et al
    Genetic variation, pathogenicity, and immunogenicity of highly pathogenic porcine reproductive and respiratory syndrome virus strain XH-GD at different passage levels.
    Arch Virol. 2016;161:77-86.
    PubMed     Text format     Abstract available


    September 2015
  44. LEI H, Peng X, Zhao D, Jiao H, et al
    Cross-protection of Lactococcus lactis-displayed HA2 subunit against homologous and heterologous influenza A viruses in mice.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: